Medications for opioid use disorder

The video trainings provided here were created by staff and faculty at the University of Washington’s Addictions, Drug & Alcohol Institute and the UW School of Medicine, along with community partners.

Individual Sessions

• • Long Acting, Injectable Buprenorphine for Opioid Use Disorder (April 2021)

• • Low-Dose Buprenorphine Induction for Pain and Opioid/Fentanyl Use Disorder (February 2021)

• • Opioid Use Disorder Medications and Shared Decision Making (2019)

• • Powerhouse Panel: Networking and Working with Opioid Treatment Programs (June 2021)

• • Introduction to the Medication-First Model for Opioid Use Disorder Treatment with Buprenorphine (November 2020)

• • When MOUD Doesn’t Go According to Plan (March 2022)

Webinar Series

• • Medications for Opioid Use Disorder in Washington State Jails (2020-2021)

• • Medications for Opioid Use Disorder in Adolescents (April-July 2021)